| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/10/2013 | CN102357117B Pogostemon cablin volatile oil, preparation method thereof and application thereof to prepare anti-tumor medicines |
| 04/10/2013 | CN102327421B Blood-activating and vitality circulation-promoting Chinese medicinal preparation for treating esophageal cancer and preparation method thereof |
| 04/10/2013 | CN102321074B Indole ring-substituted pyrazole hydrazide derivative and preparation method and application thereof |
| 04/10/2013 | CN102319391B Chinese medicinal soft capsule for treating uterine fibroid and preparation method thereof |
| 04/10/2013 | CN102302567B Stagnation-removing and stasis-removing Chinese patent medicine |
| 04/10/2013 | CN102296052B Specific antigenic peptide of polyclonal antibody aiming at ppGalNAc-T13, and its preparation method and use |
| 04/10/2013 | CN102295709B Ganoderma lucidum polysaccharide with light color and high molecular weight, and preparation method thereof |
| 04/10/2013 | CN102276579B Oligothiophene and preparation method and application thereof |
| 04/10/2013 | CN102266434B Chinese medicinal composition for resisting tumor metastasis and preparation method thereof |
| 04/10/2013 | CN102229671B Anti-IMMT anthropogenic Fab antibody and application thereof in preparing anti-liver cancer drugs |
| 04/10/2013 | CN102228437B Co-immobilized TNF-a/IFN-g/DOX/FA/Fe3O4-OA magnetic targeted nanoparticle as well as preparation method and application thereof |
| 04/10/2013 | CN102210843B Chinese medicine composition for treating malignant tumors and application thereof |
| 04/10/2013 | CN102206222B 2-fatty-amino-substituted indole quinoline derivative and preparation method and application thereof in preparation of antitumor drugs |
| 04/10/2013 | CN102204919B Application of bufotalin to preparation of medicament for treating intracranial tumors |
| 04/10/2013 | CN102180969B Monoclonal antibody with liver cancer resisting activity and application thereof |
| 04/10/2013 | CN102166190B Paclitaxel nano liposomes of dual targeting tumor and method for preparing paclitaxel nano liposomes |
| 04/10/2013 | CN102140469B Human miR (microRNA)-1233 antisensenucleic acid and application thereof |
| 04/10/2013 | CN102139019B Application of camellia oleifera peel extract |
| 04/10/2013 | CN102127067B 2-(6-aminobenzothiazole-2-mercapto)-acetamide derivatives and preparation method and applications thereof |
| 04/10/2013 | CN102105148B Therapeutic combination comprising an AURORA kinase inhibitor and antiproliferative agents |
| 04/10/2013 | CN102093376B Furocoumarin compound and application thereof |
| 04/10/2013 | CN102091067B New application of furocoumarin compound in preparing drug |
| 04/10/2013 | CN102078621B Method and composition of regulating and controlling plasmacytoid dendritic cell I type interferon expression |
| 04/10/2013 | CN102058878B Prosoma pellet tablet for generating allicin in stomach and preparation method thereof |
| 04/10/2013 | CN102010425B 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/10/2013 | CN101941953B Nitrogenous heterocyclic substituted hydrazide compounds as well as preparation methods and applications thereof |
| 04/10/2013 | CN101899443B Method for regulating and controlling FAF1 (Fas-associated Factor-1) genes, composition and application thereof |
| 04/10/2013 | CN101874807B Application of lanosterol and tuckahoe extract in treating cachexia |
| 04/10/2013 | CN101863926B Antitumor drug palladium coordination compound |
| 04/10/2013 | CN101817813B Crystal IV of 3-(substituted dihydroisoindolinone-2-yl)-2,6-piperidinediketone and medicinal composite thereof |
| 04/10/2013 | CN101775375B Preparation method of recombinant adeno-associated viruses containing EB virus latent membrane protein 1 and 2 genes and application thereof |
| 04/10/2013 | CN101732377B Method for preparing anti-cancer total saponin extracts of oplopanax elatus nakai leaves |
| 04/10/2013 | CN101721411B Use of derivative of phenanthroline in preparation of drug |
| 04/10/2013 | CN101711280B TEM8 peptides and vaccines comprising the same |
| 04/10/2013 | CN101700394B Pharmaceutical composite for curing colon cancer and preparing method thereof |
| 04/10/2013 | CN101686981B Diazo bicyclic smac mimetics and the uses thereof |
| 04/10/2013 | CN101585860B 4',5,6-trimethoxy scutellarin as well as preparation method and pharmaceutical composition thereof |
| 04/10/2013 | CN101579312B Teniposide liposome and preparation method thereof |
| 04/10/2013 | CN101456886B Use of daphne primeverose-genkwanin and daphne plant |
| 04/10/2013 | CN101454334B Macrolide derivatives |
| 04/10/2013 | CN101440086B Halogenated pyrrole substituted indolinones, and intermediate, preparation and use thereof |
| 04/10/2013 | CN101415730B Compositions and methods of use for antibodies of c-Met |
| 04/10/2013 | CN101230045B Aromatic triazin derivatives and uses thereof |
| 04/09/2013 | US8415453 polynucleotides, polypeptides and antibodies for use in medical diagnosis and therapy; polypeptides coupled to liposomes containing the anticarcinogenic agents, having improved efficiency and reduced side effects |
| 04/09/2013 | US8415362 Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 04/09/2013 | US8415355 Pyrrolopyrimidine compounds and their uses |
| 04/09/2013 | US8415348 Nitrogenated derivatives of pancratistatin |
| 04/09/2013 | US8415318 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 04/09/2013 | US8415317 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 04/09/2013 | US8415303 Method of treatment using a soluble human delta protein fragment |
| 04/09/2013 | US8415152 Therapeutical composition containing dentritic cells and use thereof |
| 04/09/2013 | US8414900 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 04/09/2013 | US8414898 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/09/2013 | US8414895 Tweak receptor |
| 04/09/2013 | US8414894 Human antibodies that bind human TNFα and methods of using same |
| 04/09/2013 | CA2737565C N-phenyl-2-pyrimidine-amine derivatives |
| 04/09/2013 | CA2695605C Pyrazolone derivative emulsion formulations |
| 04/09/2013 | CA2659590C Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 04/09/2013 | CA2598454C Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
| 04/09/2013 | CA2587642C Substituted heterocycles and methods of use |
| 04/09/2013 | CA2572833C Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 04/09/2013 | CA2569827C Quinazolinedione derivatives as parp inhibitors |
| 04/09/2013 | CA2531050C Pharmaceutical compounds |
| 04/09/2013 | CA2527192C Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 04/09/2013 | CA2450777C Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 04/09/2013 | CA2325341C Mutagenized il13-based chimeric molecules |
| 04/04/2013 | WO2013049859A1 Treating pancreatic cancer and non-small cell lung cancer with atr inhibitors |
| 04/04/2013 | WO2013049726A2 Processes for making compounds useful as inhibitors of atr kinase |
| 04/04/2013 | WO2013049722A1 Compounds useful as inhibitors of atr kinase |
| 04/04/2013 | WO2013049720A1 Compounds useful as inhibitors of atr kinase |
| 04/04/2013 | WO2013049719A1 Compounds useful as inhibitors of atr kinase |
| 04/04/2013 | WO2013049617A1 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/04/2013 | WO2013049600A1 Compositions for rf ablation |
| 04/04/2013 | WO2013049565A1 Imidazole derivatives as cyp17 inhibitors for the treatment of cancer |
| 04/04/2013 | WO2013049350A1 Smac mimetic (birinapant) for use in the treatment of proliferative diseases (cancer) |
| 04/04/2013 | WO2013049300A1 Method of treating mucoepidermoid carcinoma |
| 04/04/2013 | WO2013049263A1 Substituted bicyclic heteroaryl compounds |
| 04/04/2013 | WO2013049254A1 Hybrid constant regions |
| 04/04/2013 | WO2013048832A1 18 f - labelled 6 - ( 2 - fluoroethoxy) - 2 - naphthaldehyde for detecting cancer stem cells |
| 04/04/2013 | WO2013048452A2 Small-molecule tnf modulator to reduce the side effects of chemotherapy and radiotherapy |
| 04/04/2013 | WO2013048345A1 Methods and pharmaceutical compositions for treating cancer |
| 04/04/2013 | WO2013048164A1 NOVEL COMPOUNDS AS HIF-1αINHIBITORS AND MANUFACTURING PROCESS THEREOF |
| 04/04/2013 | WO2013048116A2 Erythropoietin-derived peptide and use therefor |
| 04/04/2013 | WO2013048022A2 Α-type zinc- phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an α-type zinc- phthalocyanine nanowire/phenothiazine, and method for preparing same |
| 04/04/2013 | WO2013047941A1 Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of tm4sf4 in non-small cell lung cancer |
| 04/04/2013 | WO2013047846A1 Glycosylated polypeptide and pharmaceutical composition containing same |
| 04/04/2013 | WO2013047813A1 1,2,4-triazine-6-carboxamide derivative |
| 04/04/2013 | WO2013047758A1 Crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate, crystal of 5-hydroxy-1h-imidazole-4-carboxamide 3/4 hydrate, and method for producing same |
| 04/04/2013 | WO2013047752A1 Antigen-binding molecule for promoting loss of antigens |
| 04/04/2013 | WO2013047729A1 Antigen-binding molecule inducing immune response to target antigen |
| 04/04/2013 | WO2013047509A1 Novel phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition |
| 04/04/2013 | WO2013046223A1 An improved process for the preparation of bendamustine hydrochloride |
| 04/04/2013 | WO2013046136A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
| 04/04/2013 | WO2013046041A1 Pyridinylpyrazoles for use as kinase modulators for the treatment of cancer |
| 04/04/2013 | WO2013045955A1 Prevention and/or treatment of cancer and/or cancer metastasis |
| 04/04/2013 | WO2013045826A1 Compositions containing spermine together with cadaverine, putrescine and/or spermidine |
| 04/04/2013 | WO2013045707A2 Biological materials related to c-met |
| 04/04/2013 | WO2013045653A1 Macrocyclic flt3 kinase inhibitors |
| 04/04/2013 | WO2013045580A1 Anti-icam-1 antibodies to treat multiple-myeloma related disorders |
| 04/04/2013 | WO2013045461A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |